Ads
related to: kadcyla cancer drug- Side Effects & Tips
Understand Potential Side Effects
When Taking KADCYLA® As A Treatment
- How KADCYLA® May Work
View The Safety Of KADCYLA® And How
The Treatment Is Thought To Work.
- Taking KADCYLA®
Learn How KADCYLA® Is Given & Ask
Your Doctor If It Is Right For You.
- Questions For Your Doctor
Find Important Prescribing And
Safety Questions To Ask Here.
- HERConnection Support
Discover A Free Support Program For
Patients Currently Taking KADCYLA®.
- Financial Information
View Financial Resources That May
Help You Pay For Treatment.
- Side Effects & Tips
Search results
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
Merck cancer drug deal caps pharma investment influx into ‘ADC’ field
BioPharma Dive via Yahoo Finance· 7 months agoWith the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential...
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
Reuters via Yahoo News· 2 years agoMANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs),...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 6 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 1 week agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 9 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
New data sets stage for broader use of AstraZeneca breast cancer drug
Reuters via Yahoo News· 2 years agoAstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 10 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Ads
related to: kadcyla cancer drug